Neutralization of recombinant hirudin: some practical considerations

Semin Thromb Hemost. 1991 Apr;17(2):137-44. doi: 10.1055/s-2007-1002602.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Animals
  • Blood Coagulation Tests
  • Blood Loss, Surgical / prevention & control
  • Factor VIIa / pharmacology
  • Factor VIIa / therapeutic use
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / pharmacology
  • Fibrinolytic Agents / therapeutic use
  • Hemorrhage / chemically induced
  • Hemorrhage / prevention & control*
  • Heparin / adverse effects
  • Hirudin Therapy
  • Hirudins / adverse effects
  • Hirudins / antagonists & inhibitors*
  • Hirudins / pharmacology
  • Humans
  • Platelet Aggregation / drug effects
  • Rabbits
  • Recombinant Fusion Proteins / adverse effects
  • Recombinant Fusion Proteins / antagonists & inhibitors
  • Recombinant Fusion Proteins / pharmacology
  • Recombinant Fusion Proteins / therapeutic use

Substances

  • Fibrinolytic Agents
  • Hirudins
  • Recombinant Fusion Proteins
  • Heparin
  • Factor VIIa